Levisa Pharma|NewsPTENESTalk to Levisa →

ANVISA Regulatory

ANVISA releases guidance manuals to facilitate medical device registration

Levisa Pharma Newsroom · sourced from ANVISA

August 28, 2026 · 5:35 PM

ANVISA releases guidance manuals to facilitate medical device registration • ANVISA/Handout

The National Health Surveillance Agency (ANVISA) has made available guidance manuals aimed at facilitating the regulatory process for medical devices. The initiative seeks to guide manufacturers, importers, and other interested parties regarding the procedures and requirements necessary to obtain regulatory approval from the agency.

The manuals developed by ANVISA provide detailed instructions covering the stages involved in regularization, from initial documentation to final approval. The informational material intends to address common questions and standardize understanding of the technical and administrative requirements demanded by the agency.

This measure is part of ANVISA's regulatory strategy focused on transparency and facilitation of product approval processes. By providing clear and accessible guidance, the agency aims to improve communication with the regulated sector and expedite the processing of applications.

The manuals address different categories of medical devices and emphasize good practices required throughout the product lifecycle, from development to commercialization. Adequate technical documentation, compliance with international technical standards, and demonstration of safety and performance are key points covered in the materials.

The availability of these manuals represents progress in standardizing regulatory processes and establishing clear criteria for companies wishing to market medical devices in the Brazilian market. Interested companies can access the manuals through ANVISA's official portal by consulting sections dedicated to medical device regularization.

Editorial content by Levisa Pharma for compounding pharmacies and licensed professionals. Not therapeutic guidance.

Read more

Adverse event notifications for cosmetics increase 130% following new Anvisa regulations

09/11/2026

Anvisa implements risk-based inspection for dental services with new guidance

09/11/2026

Compounding pharmacy: understand the process behind personalized medicines

09/11/2026